(Q34991396)

5 August 2017

Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute (English)

1 reference

5 August 2017

1 reference

1 reference

Ribeiro G

1

1 reference

PubMed ID

6403101

5 August 2017

Palmer MK

series ordinal

2

1 reference

PubMed ID

6403101

5 August 2017

language of work or name

English

0 references

publication date

1 March 1983

1 reference

5 August 2017

1 reference

5 August 2017

286

1 reference

5 August 2017

827-830

1 reference

5 August 2017

6368

1 reference

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1547148

Tamoxifen in advanced breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1547148

Tamoxifen as an anti-tumour agent: effect on oestrogen binding

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1547148

Manchester regional breast study. Preliminary results

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1547148

8 July 2018

Identifiers

PMCID

1547148

1 reference

5 August 2017

1 reference

PubMed ID

6403101